Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis-Reference-Cited by-同舟云学术

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis

Published:2020-10 Issue:4 Volume:6 Page:00451-2020
ISSN:2312-0541
Container-title:ERJ Open Research
language:en
Short-container-title:ERJ Open Res

Author:

Nanzer Alexandra M.^ORCID,Dhariwal Jaideep^ORCID,Kavanagh Joanne,Hearn Andrew,Fernandes Mariana,Thomson Louise,Roxas Cris,Green Linda,D'Ancona Grainne,Agarwal Sangita,Kent Brian D.,Jackson David J.^ORCID

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference9 articles.

1. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

2. Burden of systemic glucocorticoid-related complications in severe asthma;Lefebvre;Curr Med Res Opin,2017

3. Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial;Puechal;Rheumatology (Oxford),2019

4. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

5. Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis;Journal of Asthma and Allergy;2024-06

2. Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA);European Journal of Internal Medicine;2024-06

3. Burden of eosinophilic granulomatosis with polyangiitis in Europe;ERJ Open Research;2024-05-02

4. Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis;Frontiers in Medicine;2024-03-22

5. Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis;The Journal of Allergy and Clinical Immunology: In Practice;2024-03